Literature DB >> 11268299

Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going?

C Elias1, C Coggins.   

Abstract

Acceptability research is an important component of any product development process. As researchers move into a new, accelerated phase of vaginal microbicide development, it is important to take stock of the acceptability research conducted to date and determine future research priorities. In this paper, we review findings from acceptability research conducted to date in four categories: hypothetical product acceptability research, existing product research (spermicide acceptability studies), acceptability research within the context of clinical trials, and postmarketing acceptability research conducted around the female condom. Finally, we highlight areas where additional research is needed in light of recent progress in microbicide development and discuss a possible framework for the introduction and acceptability of new sexually transmitted disease (STD) prevention technologies.

Mesh:

Substances:

Year:  2001        PMID: 11268299     DOI: 10.1089/152460901300039502

Source DB:  PubMed          Journal:  J Womens Health Gend Based Med        ISSN: 1524-6094


  33 in total

Review 1.  Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions.

Authors:  A M Minnis; N S Padian
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

2.  Integrating behavioral and social science research into microbicide clinical trials: challenges and opportunities.

Authors:  Elizabeth E Tolley; Lawrence J Severy
Journal:  Am J Public Health       Date:  2005-11-29       Impact factor: 9.308

3.  Assessing microbicide acceptability: a comprehensive and integrated approach.

Authors:  Kathleen M Morrow; Monica S Ruiz
Journal:  AIDS Behav       Date:  2007-06-26

4.  Acceptability of hypothetical microbicides among women in sex establishments in rural areas in Southern China.

Authors:  Yu Wang; Su-Su Liao; Margaret R Weeks; Jing-Mei Jiang; Maryann Abbott; Yue-Jiao Zhou; Bin He; Wei Liu; Katie E Mosack
Journal:  Sex Transm Dis       Date:  2008-01       Impact factor: 2.830

Review 5.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

6.  Vaginal microbicide preferences among midwestern urban adolescent women.

Authors:  Amanda E Tanner; Jennifer M Katzenstein; Gregory D Zimet; Dena S Cox; Anthony D Cox; J Dennis Fortenberry
Journal:  J Adolesc Health       Date:  2008-06-05       Impact factor: 5.012

Review 7.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

Review 8.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

9.  Acceptability and use of sexual barrier products and lubricants among HIV-seropositive Zambian men.

Authors:  D L Jones; S M Weiss; N Chitalu; M Mumbi; A Shine; S Vamos; O Villar
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

10.  Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa.

Authors:  Elizabeth T Montgomery; Helen Cheng; Ariane van der Straten; Agnes C Chidanyika; Naomi Lince; Kelly Blanchard; Gita Ramjee; Busisiwe Nkala; Nancy S Padian
Journal:  AIDS Behav       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.